You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
|No Recent Quote currently available|
My Portfolio Tracker
One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today.
Jan 09, 2013 (SmarTrend(R) Upgrades/Downgrades via COMTEX) -- Monsanto (NYSE:MON) was downgraded from Buy to Hold at Miller Tabak today. The stock closed yesterday at $98.50 on volume of 7.4 million shares, above average daily volume of 2.3 million. Potential upside of 6.0% exists for Monsanto, based on a current level of $98.50 and analysts' average consensus price target of $104.38. Monsanto shares have support at the 50-day moving average (MA) of $90.07 and additional support at the 200-day MA of $84.43.
Monsanto Company provides agricultural products for farmers. The Company's business segments are seeds and genomics. Monsanto produces a wide range of seeds and develops biotechnology traits that assist farmers in controlling insects andweeds as well as provides other seed companies with genetic material and biotechnology traits for their seed brands.
Over the past year, Monsanto has traded in a range of $69.70 to $99.99 and closed yesterday at $98.50, 41% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.6% while the 200-day MA has risen 0.3%.
SmarTrend recommended that subscribers consider buying shares of Monsanto on November 20th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $88.71. Since that recommendation, shares of Monsanto have risen 11.0%. We continue to monitor MON for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Write to Chip Brian at firstname.lastname@example.org
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup
Copyright, Comtex News Network, Inc. 2013
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Copyright 2015 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.